Rapid progress in stem cell research has raised hopes in patients afflicted with serious diseases for possible new stem cell-based therapies. With the exception of hematopoietic stem cell transplants for leukemia and epithelial stem cell-based treatments for skin burns and corneal disorders, clinical translation for other diseases may still require many more years of pre-clinical

